RAPT Therapeutics, Inc. (RAPT) — Institutional Holders, Q4 2025 (page 2)
106 institutional investment managers reported a RAPT position on SEC Form 13F-HR for the quarter ended December 31, 2025, with a combined reported value of $1.0B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 106. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
RAPT 13F holders ranked 101–106 of 106
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q3 2025 |
|---|---|---|---|---|---|
| 101 | ROYAL BANK OF CANADA#101 · 35 sh | 35 | $1.0K | — | -99.8% |
| 102 | CWM#102 · 32 sh | 32 | $1.0K | — | -71.7% |
| 103 | EverSource Wealth Advisors#103 · 20 sh | 20 | $678.00 | — | -65.5% |
| 104 | Allworth Financial#104 · 7 sh | 7 | $238.00 | — | New |
| 105 | Aster Capital Management (DIFC) Ltd#105 · 1 sh | 1 | $34.00 | — | New |
| 106 | BESSEMER GROUP#106 · 11 sh | 11 | $0.00 | — | 0.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q4 2025. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q3 2025 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.